Emulate Inc, based in Boston, MA, offers a cutting-edge platform for modeling the holistic journey of solid tumor cell therapy through organ chips. Their innovative technology allows researchers to simulate key processes such as vascular administration, endothelial attachment, T cell migration, and antigen-specific killing in a vascularized cancer cell line model.
With a focus on reducing translational failure and improving human disease research, Emulate's human emulation system provides unparalleled insights into the inner workings of human biology. Their platform, comprised of instruments, consumables, and software, is user-friendly and flexible, offering researchers a powerful tool for advancing research and drug development in various fields such as cancer gene therapy, immunology, infectious disease, and neuroscience.
Generated from the website